Legacy Pharmaceuticals bankrupt: 260 jobs disappear
Legacy Pharmaceuticals announces bankruptcy.
The pharmaceutical subcontractor Legacy Pharmaceuticals Switzerland has announced its liquidation following the “significant” payment default of one of its clients. All 260 employees will lose their jobs. The Birsfelden group is about to file for bankruptcy with the competent court.
It is because of its insolvency, aggravated by the default of payment of an “important customer” causing a “significant impact”, that the company took the path of liquidation, specifies Wednesday Legacy Pharmaceuticals Switzerland. The Basel-based company now rules out any possibility of restructuring.
Legacy Pharmaceuticals Switzerland ensures that the 260 employees are supported both by the human resources department and by the competent authorities.
These were the details of the news Legacy Pharmaceuticals bankrupt: 260 jobs disappear for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at en24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.